NCT03705949View on ClinicalTrials.gov

Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

September 15, 2018

Study Completion Date

September 15, 2018

Conditions
Cataract
Interventions
DRUG

Sodium Hyaluronate 0.1% drops

Patients will be administered Drops of Sodium Hyaluronate 0.1% quid

DRUG

Sodium Hyaluronate 0.2% drops

Patients will be administered Drops of Sodium Hyaluronate 0.2% quid

Trial Locations (1)

68100

University Hospital of Alexandroupolis, Alexandroupoli

All Listed Sponsors
collaborator

Naval Hospital, Athens

OTHER

collaborator

George Papanicolaou Hospital

OTHER

collaborator

Athinaiki General Clinic

OTHER

lead

Democritus University of Thrace

OTHER

NCT03705949 - Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery | Biotech Hunter | Biotech Hunter